Summary
Gene-based immunization with transgenic DNA vectors expressing tumor-associated antigens (TAA), cytokines, or chemokines, alone or in combination, provides an attractive approach to increase the cytotoxic T cell immunity against various cancer diseases. With this consideration, particle-mediated or gene gun technology has been developed as a nonviral method for gene transfer into various mammalian tissues. It has been shown to induce both humoral and cell-mediated immune responses in both small and large experimental animals. A broad range of somatic cell types, including primary cultures and established cell lines, has been successfully transfected ex vivo or in vitro by gene gun technology, either as suspension or adherent cultures. Here, we show that protocols and techniques for use in gene gun-mediated transgene delivery system for skin vaccination against melanoma using tumor-associated antigen (TAA) human gp100 and reporter gene assays as experimental systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Condon, C., Watkins, S.C., Celluzzi, C.M., Thompson, K., and Falo, L.D. Jr. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2, 1122–1128.
Yang, N.S., Burkholder, J., Roberts, B., Martinell, B., and McCabe, D. (1990). In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568–9572.
Cheng, L., Ziegelhoffer, P., and Yang, N.S. (1993). In vivo promoter activity and transgenic expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4454–4459.
Pertmer, T.M., Eisenbraun, M.D., McCabe, D., Prayaga, S.K., Fuller, D.H., and Haynes, J.R. (1995). Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427–1430.
Feltquate, D.M., Heaney, S., Webster, R.G., and Robinson, H.L. (1997). Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158, 2278–2284.
Rakhmilevich, A. L., Turner, J., Ford, M. J., McCabe, D., Sun, W. H., Sondel, P. M., et al. (1996). Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl. Acad Sci USA 93, 6291–6296.
Fuller, D.H., Corb, M.M., Barnett, S., steamer, K., and Haynes, J.R. (1997). Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 15, 924–926.
Yamano, T., Kaneda, Y., Huang, S., Hiramatsu, S.H., and Hoon, D.S.B. (2006). Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. Mol. Ther. 13, 194–202.
Yang, S.C., Batra, R.K., Hillinger, S., Reckamp, K.L., Strieter, R.M., Dubinett, S.M.et al. (2006). Intrapulmonary administration of CCL21 gene-modified dendritic cells reduced tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 66, 3205–3213.
Lian, H., Jin, N., Li, X., Mi, Z., Zhang, J., Sun, L. et al., (2007). Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and apoptin. Cancer Immunol. Immunother. 56, 181–192.
Mahvi, D.M., Sondel, P.M., Yang, N.S., Albertini, M.R., Schiller, J.H., Hank, J., et al. (1997). Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma. Hum. Gene Ther. 8, 875–891.
Cassaday, R.D., Sondel, P.M., King, D.M., Macklin, M.D., Gan, J., Warner, T.F., et al. (2007). A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients. Clin. Cancer Res. 13, 540–549.
Aravindaram, K., Yu, H.H., Lan, C.W., Wang, P.H., Chen, Y.H., Chen, H.M. et al. (2009). Transgenic expression of human gp 100 and RANTES at specific time points for suppression of melanoma. Gene Ther. (under revision).
Qiu, P., Ziegelhoffer, P., Sun, J., and Yang, N.S. (1996). Gene gun delivery of mRNA in situ result in efficient transgene expression and immunization. Gene Ther. 3, 262–268.
Jiao, S., Cheng, L., Wolff, J., and Yang, N.S. (1993). Particle bombardment mediated gene transfer and expression in rat brain tissues. Bio/Technology 11, 497–502.
Burkholder, J.K., Decker, J., and Yang, N.S. (1993). Transgene expression in lymphocyte and macrophage primary cultures after particle bombardment. J. Immunol. Methods 165, 149–156.
Christou, P. (1994). Application to plants, in Particle Bombardment Technology for Gene Transfer (Yang, N.S. and Christou, P., eds.), Oxford University Press, New York, pp. 71–99.
Yang, N.S. and Ziegelhoffer, P. (1994). The particle bombardment system for mammalian gene transfer, in Particle Bombardment Technology for Gene Transfer (Yang, N.S. and Christou, P., eds.), Oxford University Press, New York, pp. 117–141.
Rakhmilevich, A.L., Imboden, M., Hao, Z., Macklin, M.D., Roberts, T., Wright, K.M., et al. (2001). Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding gp100 and granulocyte-macrophage colony-stimulating factor. Clin. Cancer Res. 7, 952–961.
Yang, N.S., Wang, J.H., Lin, K.F., Wang, C.Y., Kim, S.A., Yang, Y.L., et al. (2005). Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. J. Gene Med. 7, 708–717.
Guo, Z., Yang, N.S., Jiao, S., Sun, J., Cheng, L., Wolff, J.A., et al. (1996). Efficient and sustained transgene expression in mature rat oligodendrocytes in primary culture. J. Neurosci. Res. 43, 32–41.
Sun, W.H., Burkholder, J.K., Sun, J., Culp, J., Turner, J., Lu, X.G., et al. (1995). In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA 92, 2889–2893.
Mahvi, D.M., Burkholder, J.K., Turner, J., Culp, J., Malter, J.S., Sondel, P.M., et al. (1996). Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: Implications for a clinically relevant tumor vaccine. Hum. Gene Ther. 7, 1535–1543.
Tan, J., Yang, N.S., Turner, J.G., Niu, G.L., Maassab, H.F., Sun, J., et al. (1999). Interleukin-12 cDNA skin transfection potentiates human papillomavirus E6 DNA vaccine-induced antitumor immune response. Cancer Gene Ther. 6, 331–339.
Woffendin, C., Yang, Z., Udaykumar, K., Xu, L., Yang, N., Sheehy, M.J., et al. (1994). Non viral and viral delivery of a Human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acad. Sci. USA 91, 11581–11585.
Hogge, G.S., Burkholder, J.K., Culp, J., Albertini, M.R., Dubielzig, R.R., Yang, N.S., et al. (1999). Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs. Cancer Gene Ther. 6, 26–36.
Staniforth, V., Chiu, L.T., and Yang, N.S. (2006) Caffeic acid suppresses UVB radiation-induced expression of interleukin-10 and activation of mitogen-activated protein kinases in mouse. Carcinogenesis 27, 1803–1811.
Chiu, S.C. and Yang, N.S. (2007) Inhibition of tumor necrosis factor-alpha through selective blockade of Pre-mRNA splicing by shikonin. Mol. Pharmacol. 71, 1640–1645.
Acknowledgments
This work was supported by a grant (No. 96-2320-B-001–008) from the National Science Council and a grant (No. 95N-1003) from the National Science and Technology Program for Agricultural Biotechnology, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Aravindaram, K., Yang, N.S. (2009). Gene Gun Delivery Systems for Cancer Vaccine Approaches. In: Walther, W., Stein, U. (eds) Gene Therapy of Cancer. Methods in Molecular Biology™, vol 542. Humana Press. https://doi.org/10.1007/978-1-59745-561-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-59745-561-9_9
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-934115-85-5
Online ISBN: 978-1-59745-561-9
eBook Packages: Springer Protocols